Laboratorio Reig Jofre S.A (RJF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Laboratorio Reig Jofre S.A (RJF) has a cash flow conversion efficiency ratio of 0.056x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€11.35 Million ≈ $13.27 Million USD) by net assets (€202.27 Million ≈ $236.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Laboratorio Reig Jofre S.A - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Laboratorio Reig Jofre S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read RJF total debt and obligations for a breakdown of total debt and financial obligations.
Laboratorio Reig Jofre S.A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Laboratorio Reig Jofre S.A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bonny Worldwide Ltd
TW:8467
|
0.102x |
|
Context Therapeutics Inc
NASDAQ:CNTX
|
-0.090x |
|
Perdana Karya Perkasa Tbk
JK:PKPK
|
0.190x |
|
Hexindo Adiperkasa Tbk
JK:HEXA
|
0.038x |
|
SmartRent Inc
NYSE:SMRT
|
-0.009x |
|
Neon Equity AG
XETRA:D77
|
N/A |
|
Hanyang Digitech Co. Ltd
KQ:078350
|
0.008x |
|
Ziprecruiter Inc
NYSE:ZIP
|
-0.034x |
Annual Cash Flow Conversion Efficiency for Laboratorio Reig Jofre S.A (2005–2024)
The table below shows the annual cash flow conversion efficiency of Laboratorio Reig Jofre S.A from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see Laboratorio Reig Jofre S.A market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €213.95 Million ≈ $250.13 Million |
€31.34 Million ≈ $36.64 Million |
0.146x | +56.52% |
| 2023-12-31 | €204.25 Million ≈ $238.79 Million |
€19.11 Million ≈ $22.35 Million |
0.094x | +12.76% |
| 2022-12-31 | €194.55 Million ≈ $227.45 Million |
€16.15 Million ≈ $18.88 Million |
0.083x | +7.92% |
| 2021-12-31 | €188.51 Million ≈ $220.39 Million |
€14.50 Million ≈ $16.95 Million |
0.077x | -36.96% |
| 2020-12-31 | €184.48 Million ≈ $215.67 Million |
€22.50 Million ≈ $26.31 Million |
0.122x | +86.07% |
| 2019-12-31 | €178.14 Million ≈ $208.26 Million |
€11.68 Million ≈ $13.65 Million |
0.066x | -33.51% |
| 2018-12-31 | €149.74 Million ≈ $175.06 Million |
€14.77 Million ≈ $17.26 Million |
0.099x | -32.54% |
| 2017-12-31 | €141.56 Million ≈ $165.50 Million |
€20.69 Million ≈ $24.19 Million |
0.146x | +1407.90% |
| 2016-12-31 | €133.29 Million ≈ $155.83 Million |
€-1.49 Million ≈ $-1.74 Million |
-0.011x | -110.96% |
| 2015-12-31 | €126.17 Million ≈ $147.51 Million |
€12.87 Million ≈ $15.05 Million |
0.102x | +464.70% |
| 2014-12-31 | €118.17 Million ≈ $138.16 Million |
€-3.31 Million ≈ $-3.86 Million |
-0.028x | -110.13% |
| 2014-09-30 | €44.70 Million ≈ $52.26 Million |
€12.34 Million ≈ $14.43 Million |
0.276x | +5171.62% |
| 2013-12-31 | €75.62 Million ≈ $88.40 Million |
€396.00K ≈ $462.97K |
0.005x | +107.71% |
| 2012-12-31 | €86.75 Million ≈ $101.42 Million |
€-5.89 Million ≈ $-6.89 Million |
-0.068x | +17.29% |
| 2011-12-31 | €86.59 Million ≈ $101.23 Million |
€-7.11 Million ≈ $-8.31 Million |
-0.082x | -19.89% |
| 2010-12-31 | €73.35 Million ≈ $85.76 Million |
€-5.02 Million ≈ $-5.87 Million |
-0.068x | +72.68% |
| 2009-12-31 | €93.59 Million ≈ $109.41 Million |
€-23.46 Million ≈ $-27.43 Million |
-0.251x | -284.90% |
| 2008-12-31 | €131.95 Million ≈ $154.26 Million |
€17.89 Million ≈ $20.91 Million |
0.136x | -39.48% |
| 2007-12-31 | €140.91 Million ≈ $164.74 Million |
€31.57 Million ≈ $36.91 Million |
0.224x | +384.08% |
| 2006-12-31 | €147.74 Million ≈ $172.72 Million |
€6.84 Million ≈ $7.99 Million |
0.046x | +135.58% |
| 2005-12-31 | €79.25 Million ≈ $92.65 Million |
€-10.31 Million ≈ $-12.05 Million |
-0.130x | -- |
About Laboratorio Reig Jofre S.A
Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables … Read more